ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Mayo Clinic · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
platinum
platinum-resistant fallopian tube carcinoma, platinum-resistant ovarian carcinoma, platinum-resistant primary peritoneal carcinoma, recurrent fallopian tube carcinoma, recurrent fallopian tube carcinosarcoma, recurrent female reproductive system carcinoma, recurrent ovarian carcinoma, recurrent ovarian carcinosarcoma, recurrent platinum-resistant fallopian tube carcinoma, recurrent platinum-resistant ovarian carcinoma, recurrent primary peritoneal carcinoma, recurrent primary peritoneal carcinosarcoma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 826793
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.